Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations
- 1 July 1997
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (1) , 107-113
- https://doi.org/10.1038/bjc.1997.344
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Do-Not-Resuscitate Orders at a Teaching Hospital in JapanNew England Journal of Medicine, 1995
- Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons.Journal of Clinical Oncology, 1992
- Choice of starting dose and escalation for phase I studies of antitumor agentsCancer Chemotherapy and Pharmacology, 1992
- Response rates, duration of response, and dose response effects in phase I studies of antineoplasticsInvestigational New Drugs, 1991
- Responses and toxic deaths in Phase I clinical trialsAnnals of Oncology, 1990
- Informing Patients About Phase I Trials—How Should It Be Done?Acta Oncologica, 1989
- THERAPEUTIC RESPONSE IN PHASE-I TRIALS OF ANTINEOPLASTIC AGENTS1986
- Informed consent for investigational chemotherapy: patients' and physicians' perceptions.Journal of Clinical Oncology, 1984
- Patient motivation and informed consent in a phase I study of an anticancer agentEuropean Journal of Cancer and Clinical Oncology, 1984
- Informed Consent — Why Are Its Goals Imperfectly Realized?New England Journal of Medicine, 1980